Drug legalization, harm reduction, and drug policy.
作者信息
Wilbur D W
出版信息
Ann Intern Med. 1996 Apr 15;124(8):776. doi: 10.7326/0003-4819-124-8-199604150-00017.
Abstract
摘要
相似文献
1
Drug legalization, harm reduction, and drug policy.
Ann Intern Med. 1996 Apr 15;124(8):776. doi: 10.7326/0003-4819-124-8-199604150-00017.
2
Drug legalization, harm reduction, and drug policy.
Ann Intern Med. 1996 Apr 15;124(8):777. doi: 10.7326/0003-4819-124-8-199604150-00020.
3
Drug legalization, harm reduction, and drug policy.
Ann Intern Med. 1996 Apr 15;124(8):776. doi: 10.7326/0003-4819-124-8-199604150-00019.
4
Drug legalization, harm reduction, and drug policy.
Ann Intern Med. 1996 Apr 15;124(8):776. doi: 10.7326/0003-4819-124-8-199604150-00018.
5
Drug legalization, harm reduction, and drug policy.
Ann Intern Med. 1996 Apr 15;124(8):775-6. doi: 10.7326/0003-4819-124-8-199604150-00016.
6
Coke and smack at the drugstore: harm reductive drug legalization: an alternative to a criminalization society.
Cornell J Law Public Policy. 2006 Summer;15(3):619-64.
7
Dutch drug policy: a model for America?
J Health Soc Policy. 1997;8(3):1-15. doi: 10.1300/J045v08n03_01.
8
Harm reduction for the supply-side: its time has come.
Int J Drug Policy. 2012 Jan;23(1):20-1. doi: 10.1016/j.drugpo.2011.07.001. Epub 2011 Aug 17.
9
Harm reduction is not enough for supply side policy: a human rights-based approach offers more.
Int J Drug Policy. 2012 Jan;23(1):18-9. doi: 10.1016/j.drugpo.2011.07.005. Epub 2011 Aug 17.
10
Drug crime and criminalisation threaten progress on MDGs.
Lancet. 2010 Oct 2;376(9747):1131-2. doi: 10.1016/s0140-6736(10)61521-8.
Zotero 插件